How 340B Drug Discounts Are Driving Up Medicaid Costs By Billions

Pharmacy,,Pills,And,Box,With,Healthcare,Store,,Shelf,And,Prescription

The rapid expansion of the federal 340B drug pricing program is significantly affecting Medicaid budgets, particularly in states where managed care plans oversee prescription drug benefits.

New analysis reveals that states are losing billions in Medicaid rebates due to ineligible claims on discounted 340B drugs, driving up the overall net cost of prescription drug coverage.